Ole Paaske Hansen

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study

Dorte Nielsen, P Dombernowsky, Susanne Kornum Larsen et al. · Cancer Chemotherapy and Pharmacology · 2000 · 71 citations

Medicine, Oncology, Pharmacology +11

Prognosis of Myelomatosis on Treatment with Prednisone and Cytostatics

Ole Paaske Hansen, Bent Jessen · Scandinavian Journal of Haematology · 1973 · 32 citations

Medicine, Hematology, Pharmacotherapy +6

Phase III study of intermittent 5‐drug regimen (VBCMP) versus intermittent 3‐drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis

Ole Paaske Hansen, Nielsaage Tøffner Clausen, Aage Drivsholm et al. · Scandinavian Journal of Haematology · 1985 · 24 citations

Medicine, Oncology, Pharmacology +15

Evans' Syndrome in IgA Deficiency Episodic Autoimmune Haemolytic Anaemia and Thrombocytopenia during a 10 Years Observation Period

Ole Paaske Hansen, Christian Hjort Sørensen, Lone Bording Astrup · Scandinavian Journal of Haematology · 1982 · 21 citations

Life Sciences, Hematology, Immunology +17

Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer

Jørn Herrtedt, Paul Frost Clementsen, Ole Paaske Hansen · European Journal of Cancer · 1992 · 15 citations

Medicine, Oncology, Pharmacology +16